Skip to content
DraconiticResearch
Search Sources API
186,625 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Medicine

Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial

  • Yongheng Li
  • Rongxu Du
  • Jianhao Geng
  • Zhiyan Liu
  • Xin Sui
  • Xianggao Zhu
  • Shuai Li
  • Yangzi Zhang
  • Dapeng Ma
  • Yujun Cui
  • Hongzhi Wang
  • Yong Cai
16 more authors
  • Zhilong Wang
  • Lei Tang
  • Peng Yuan
  • Shijie Li
  • Yanli Zhu
  • Zhongwu Li
  • Xiaotian Zhang
  • Zhi Peng
  • Fei Shan
  • Shuangxi Li
  • Rulin Miao
  • Yifan Peng
  • Aiwen Wu
  • Jiafu Ji
  • Weihu Wang
  • Ziyu Li
Open at sourceDOICite

Related

  1. Prognostic impact of neoadjuvant therapy and nomogram development in early-stage and locally advanced Siewert type II adenocarcinoma of the esophagogastric junction based on the SEER database
    Pubo Shi, Pengjie Yang, Xingfu Ban +2
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy
    Haruna Komatsubara, Shugo Mizuno, Daisuke Noguchi +10
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis
    Caineng Cao, Yulu Shen, Mengyun Qiang +9
    eClinicalMedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
  4. Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. A Systematic Review and Meta-Analysis: Does Molecular Hydrogen Exert Radioprotective Effects Without Compromising the Antitumor Efficacy of Radiotherapy or Concurrent Chemoradiotherapy?
    Yu Ivy Zhang, Michiko Miyakawa, Ayako Miyakawa
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{li2026neoadjuvant,
  title = {{Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial}},
  author = {Yongheng Li and Rongxu Du and Jianhao Geng and Zhiyan Liu and Xin Sui and Xianggao Zhu and Shuai Li and Yangzi Zhang and Dapeng Ma and Yujun Cui and Hongzhi Wang and Yong Cai and Zhilong Wang and Lei Tang and Peng Yuan and Shijie Li and Yanli Zhu and Zhongwu Li and Xiaotian Zhang and Zhi Peng and Fei Shan and Shuangxi Li and Rulin Miao and Yifan Peng and Aiwen Wu and Jiafu Ji and Weihu Wang and Ziyu Li},
  journal = {BMC Medicine},
  year = {2026},
  month = oct,
  doi = {10.1186/s12916-026-05337-2},
  url = {https://link.springer.com/article/10.1186/s12916-026-05337-2},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial
AU  - Yongheng Li
AU  - Rongxu Du
AU  - Jianhao Geng
AU  - Zhiyan Liu
AU  - Xin Sui
AU  - Xianggao Zhu
AU  - Shuai Li
AU  - Yangzi Zhang
AU  - Dapeng Ma
AU  - Yujun Cui
AU  - Hongzhi Wang
AU  - Yong Cai
AU  - Zhilong Wang
AU  - Lei Tang
AU  - Peng Yuan
AU  - Shijie Li
AU  - Yanli Zhu
AU  - Zhongwu Li
AU  - Xiaotian Zhang
AU  - Zhi Peng
AU  - Fei Shan
AU  - Shuangxi Li
AU  - Rulin Miao
AU  - Yifan Peng
AU  - Aiwen Wu
AU  - Jiafu Ji
AU  - Weihu Wang
AU  - Ziyu Li
PY  - 2026
DA  - 2026/10/20
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05337-2
UR  - https://link.springer.com/article/10.1186/s12916-026-05337-2
SN  - 1741-7015
ER  -